
|Articles|February 1, 2006
Demystifying the black box warning on antidepressants: A protocol for safe prescribing in your practice
Don't let the FDA warning about suicidality discourage you from prescribing an antidepressant for the child or adolescent who needs it. These recommendations provide a guide to monitoring patients for suicidal ideation and other adverse effects.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Ultra-processed foods tied to brain differences in young children
2
FAQ: What does the new "faltering weight" guideline mean for your practice?
3
Individualized gene therapy shows early promise for SCN2A-related epileptic encephalopathy
4
Journal Club: Is laser therapy effective in temporal lobe epilepsy?
5




